IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,812,936 | -2.9% | 304,518 | -12.1% | 0.01% | 0.0% |
| Q2 2023 | $14,218,454 | +718.6% | 346,538 | +613.0% | 0.01% | +500.0% |
| Q1 2023 | $1,736,964 | -21.4% | 48,600 | -16.9% | 0.00% | 0.0% |
| Q4 2022 | $2,209,696 | -14.0% | 58,504 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $2,570,000 | +14.1% | 58,102 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $2,253,000 | -1.8% | 60,860 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $2,294,000 | -27.0% | 61,939 | -40.0% | 0.00% | 0.0% |
| Q4 2021 | $3,141,000 | +36.8% | 103,214 | +50.8% | 0.00% | 0.0% |
| Q3 2021 | $2,296,000 | -17.5% | 68,451 | -1.9% | 0.00% | 0.0% |
| Q2 2021 | $2,784,000 | -19.9% | 69,803 | -9.7% | 0.00% | -50.0% |
| Q1 2021 | $3,475,000 | -11.0% | 77,300 | +11.9% | 0.00% | 0.0% |
| Q4 2020 | $3,905,000 | +18.1% | 69,069 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $3,306,000 | -19.4% | 69,669 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $4,103,000 | +25.9% | 69,589 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $3,260,000 | -22.2% | 68,958 | -0.6% | 0.00% | 0.0% |
| Q4 2019 | $4,192,000 | +2.0% | 69,392 | +1.2% | 0.00% | -33.3% |
| Q3 2019 | $4,109,000 | -6.8% | 68,584 | -0.0% | 0.00% | 0.0% |
| Q2 2019 | $4,409,000 | -19.5% | 68,601 | +1.6% | 0.00% | -25.0% |
| Q1 2019 | $5,480,000 | +41.6% | 67,517 | -5.7% | 0.00% | +33.3% |
| Q4 2018 | $3,871,000 | +3.9% | 71,608 | -0.9% | 0.00% | +50.0% |
| Q3 2018 | $3,727,000 | +21.2% | 72,253 | -2.1% | 0.00% | 0.0% |
| Q2 2018 | $3,075,000 | -46.9% | 73,790 | -43.9% | 0.00% | -50.0% |
| Q1 2018 | $5,796,000 | +58.6% | 131,487 | +81.0% | 0.00% | +33.3% |
| Q4 2017 | $3,654,000 | -1.6% | 72,637 | -0.8% | 0.00% | 0.0% |
| Q3 2017 | $3,713,000 | -0.4% | 73,237 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $3,728,000 | +29.6% | 73,287 | +2.4% | 0.00% | +50.0% |
| Q1 2017 | $2,877,000 | -16.1% | 71,579 | -0.2% | 0.00% | -33.3% |
| Q4 2016 | $3,430,000 | +24.5% | 71,717 | -4.7% | 0.00% | +50.0% |
| Q3 2016 | $2,756,000 | +25.0% | 75,219 | -20.5% | 0.00% | 0.0% |
| Q2 2016 | $2,204,000 | -36.4% | 94,634 | +10.6% | 0.00% | -33.3% |
| Q1 2016 | $3,466,000 | -27.2% | 85,574 | +11.2% | 0.00% | -25.0% |
| Q4 2015 | $4,764,000 | – | 76,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |